시장보고서
상품코드
2098722

만성질환 관리 플랫폼 시장 보고서(2026년)

Chronic Disease Management Platforms Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,428,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,291,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,155,000
※ 부가세 별도
한글목차
영문목차

만성질환 관리 플랫폼 시장 규모는 최근 급성장하고 있습니다. 2025년 83억 3,000만 달러에서 2026년에는 95억 6,000만 달러로, CAGR 14.8%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 전 세계 만성질환 유병률 증가, 원격 의료 서비스의 보급 확대, 헬스케어 분야의 디지털 인프라 구축, 환자에 대한 지속적인 모니터링 수요 증가, 그리고 웨어러블 의료기기의 도입 확대 등을 들 수 있습니다.

만성질환 관리 플랫폼 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 167억 2,000만 달러에 이르고, CAGR은 15.0%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 임상 의사결정 지원 시스템에 인공지능(AI)을 접목하는 것, 가치 주도형 헬스케어 모델의 확산, 원격 환자 모니터링 활동의 확대, 헬스케어 데이터 시스템 간의 상호 운용성에 대한 중요성 증대, 그리고 맞춤형 의료 접근법의 채택 확대 등을 들 수 있습니다. 예측 기간 동안의 주요 동향으로는 만성질환 위험 평가를 위한 AI 기반 예측 분석 플랫폼, IoT 기반의 원격 환자 모니터링 생태계, 클라우드 기반의 상호 운용 가능한 전자의무기록 통합 시스템, 정밀 의학을 지향하는 맞춤형 만성질환 치료 경로, 그리고 블록체인을 활용한 안전한 환자 데이터 교환 플랫폼 등이 있습니다.

생활습관병 유병률 증가가 향후 만성질환 관리 플랫폼 시장의 성장을 견인할 것으로 예측됩니다. 생활습관병이란 주로 건강에 해로운 습관이나 행동(부적절한 식습관, 운동 부족, 흡연, 과도한 음주 등)에 의해 유발되는 질환을 말합니다. 생활습관병 유병률의 상승은 사무 업무나 디지털 기기 사용에 장시간을 할애하고 신체 활동이 제한된 사람들이 늘어남에 따라, 앉아 있는 생활 방식이 증가하고 있는 데 기인합니다. 만성질환 관리 플랫폼은 지속적인 모니터링, 맞춤형 치료, 복약 관리, 조기 위험 감지를 지원하여 당뇨병, 비만, 고혈압, 심혈관 질환 등의 생활습관병 관리를 돕습니다. 예를 들어, 2024년 6월 영국 정부 기관인 국민보건서비스(NHS)에 따르면, 2023년 NHS는 잉글랜드에서 2형 당뇨병 발병 위험이 있는 추가 환자 50만 명 이상(54만 9,000명) 확인되었으며, 주치의에 등록된 비당뇨성 고혈당, 즉 당뇨병 전단계 환자의 총 수는 361만 5,330명에 달했습니다. 이는 2022년의 306만 5,825명과 비교해 대폭 증가한 수치로, 약 20%의 상승세를 보여주고 있습니다. 따라서 생활습관병 유병률 증가가 만성질환 관리 플랫폼 시장의 성장을 견인하고 있습니다.

만성질환 관리 플랫폼 시장에서 사업을 전개하는 주요 기업들은 환자 참여도 향상, 복약 순응도 증진, 만성질환의 실시간 추적 및 맞춤형 치료 제공을 실현하기 위해 디지털 테라퓨틱스 및 원격 환자 모니터링 플랫폼과 같은 혁신적인 솔루션 개발에 주력하고 있습니다. 디지털 테라퓨틱스와 원격 모니터링 플랫폼은 연결형 의료기기, 모바일 애플리케이션, 클라우드 기반 분석, 임상 지원 시스템을 통합한 기술을 활용한 헬스케어 솔루션으로, 만성질환을 원격으로 모니터링 및 관리함으로써 기존의 대면식 질환 관리 접근 방식을 대체하는 보다 적극적이고 데이터 기반의 대안을 제공합니다. 예를 들어, 2025년 12월, 미국 식품의약국(US FDA)은 만성질환 관리 솔루션을 포함한 혁신적인 의료기기 및 디지털 헬스 기술의 개발과 상용화를 가속화하기 위한 노력의 일환으로 ‘제품 수명 주기 전반에 걸친 자문 프로그램(TAP) 파일럿’을 도입했습니다. 이 프로그램은 의료기기 개발자에게 제품 수명 주기 전반에 걸쳐 초기 단계 및 전략적 규제 지침, 양방향 피드백, 그리고 협력적인 지원을 제공합니다. 이는 규제 절차를 효율화하고 제품의 안전성, 유효성, 상호운용성을 강화함으로써 환자들이 고품질의 디지털 헬스케어 기술을 보다 쉽게 이용할 수 있도록 하는 것을 목표로 합니다.

자주 묻는 질문

  • 만성질환 관리 플랫폼 시장 규모는 어떻게 변화하고 있나요?
  • 만성질환 관리 플랫폼 시장의 성장 요인은 무엇인가요?
  • 생활습관병 유병률 증가가 만성질환 관리 플랫폼 시장에 미치는 영향은 무엇인가요?
  • 만성질환 관리 플랫폼에서 주요 기업들은 어떤 혁신적인 솔루션을 개발하고 있나요?
  • 미국 식품의약국(US FDA)의 만성질환 관리 솔루션 관련 프로그램은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 시장 및 업계 지표 : 국가별

제11장 지역별/국가별 분석

제12장 아시아태평양 시장

제13장 중국 시장

제14장 인도 시장

제15장 일본 시장

제16장 호주 시장

제17장 인도네시아 시장

제18장 한국 시장

제19장 대만 시장

제20장 동남아시아 시장

제21장 서유럽 시장

제22장 영국 시장

제23장 독일 시장

제24장 프랑스 시장

제25장 이탈리아 시장

제26장 스페인 시장

제27장 동유럽 시장

제28장 러시아 시장

제29장 북미 시장

제30장 미국 시장

제31장 캐나다 시장

제32장 남미 시장

제33장 브라질 시장

제34장 중동 시장

제35장 아프리카 시장

제36장 시장 규제 상황과 투자환경

제37장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹과 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문, 전략

제42장 부록

JHS 26.08.05

Chronic disease management platforms are digital healthcare systems developed to facilitate the ongoing monitoring, coordination, and management of long-term medical conditions such as diabetes, cardiovascular disorders, asthma, and chronic respiratory diseases. These platforms utilize integrated data, remote patient monitoring, analytical tools, and communication technologies to support proactive healthcare delivery, improve adherence to treatment plans, and assist clinical decision-making throughout the care continuum.

The primary types of chronic disease management platforms include solutions and services. Solutions refer to digital platforms or software-driven systems designed to monitor, manage, and support long-term disease care while enhancing patient engagement. These platforms are classified according to disease type, including cardiovascular diseases, diabetes, cancer, respiratory diseases, and other disease categories, with key end users consisting of healthcare providers and healthcare payers.

Tariffs are influencing the chronic disease management platforms market by increasing the cost of imported digital health infrastructure, cloud computing hardware, and connected medical devices used in remote monitoring and care coordination systems. This is slowing platform deployment and integration, particularly in emerging economies and import-reliant regions such as Asia-Pacific and Latin America where healthcare systems depend on global technology providers. Software-driven segments like remote patient monitoring solutions and healthcare analytics platforms are most affected due to reliance on cross-border data infrastructure and device ecosystems. However, tariffs are also encouraging localization of digital health platforms, development of regional cloud infrastructure, and increased investment in domestic healthcare IT ecosystems, strengthening long-term resilience in chronic care management.

The chronic disease management platforms market size has grown rapidly in recent years. It will grow from $8.33 billion in 2025 to $9.56 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases globally, growing adoption of telehealth services, growth in healthcare digital infrastructure, increasing demand for continuous patient monitoring, advancements in wearable medical device adoption.

The chronic disease management platforms market size is expected to see rapid growth in the next few years. It will grow to $16.72 billion in 2030 at a compound annual growth rate (CAGR) of 15.0%. The growth in the forecast period can be attributed to the incorporation of artificial intelligence within clinical decision support systems, the widening adoption of value-driven healthcare models, the expansion of remote patient monitoring initiatives, the rising emphasis on interoperability across healthcare data systems, and the growing uptake of personalized medicine approaches. Major trends in the forecast period include AI-enabled predictive analytics platforms for chronic disease risk assessment, IoT-based remote patient monitoring ecosystems, cloud-supported interoperable electronic health record integration systems, precision medicine-oriented personalized chronic care pathways, and blockchain-powered secure patient data exchange platforms.

The increasing prevalence of lifestyle-related diseases is expected to drive the growth of the chronic disease management platforms market going forward. Lifestyle-related diseases refer to illnesses primarily caused by unhealthy habits and behaviors such as poor diet, physical inactivity, smoking, and excessive alcohol consumption. The rising prevalence of lifestyle-related diseases is attributed to increasing sedentary behavior, as more individuals spend extended hours sitting at desks, using digital devices, and engaging in limited physical activity. Chronic disease management platforms support continuous monitoring, personalized care, medication tracking, and early risk detection to assist in managing lifestyle-related conditions such as diabetes, obesity, hypertension, and cardiovascular diseases. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of lifestyle-related diseases is driving the growth of the chronic disease management platforms market.

Key companies operating in the chronic disease management platforms market are focusing on the development of innovative solutions, such as digital therapeutics and remote patient monitoring platforms, to improve patient engagement, enhance medication adherence, and enable real-time tracking of chronic conditions along with personalized care delivery. Digital therapeutics and remote monitoring platforms are technology-enabled healthcare solutions that integrate connected medical devices, mobile applications, cloud-based analytics, and clinical support systems to remotely monitor and manage chronic diseases, providing a more proactive and data-driven alternative to conventional in-person disease management approaches. For example, in December 2025, the U.S. Food and Drug Administration (US FDA) introduced the Total Product Life Cycle Advisory Program (TAP) Pilot, an initiative aimed at accelerating the development and commercialization of innovative medical devices and digital health technologies, including chronic disease management solutions. The program offers early-stage and strategic regulatory guidance, interactive feedback, and collaborative support to medical device developers across the entire product lifecycle. It is designed to enhance patient access to high-quality digital healthcare technologies by streamlining regulatory pathways and strengthening product safety, effectiveness, and interoperability.

In March 2026, Health Recovery Solutions LLC, a US-based healthcare technology company, acquired Rimidi Inc. for an undisclosed amount. Through this acquisition, Health Recovery Solutions aims to expand and strengthen its remote patient monitoring and chronic disease management capabilities by integrating Rimidi's EHR-connected clinical workflows, diabetes management solutions, and continuous glucose monitoring (CGM) expertise into its enterprise virtual care platform. Rimidi Inc. is a US-based healthcare technology company specializing in EHR-integrated remote patient monitoring software, chronic disease management solutions, and connected care technologies.

Major companies operating in the chronic disease management platforms market are Oracle Corporation, Koninklijke Philips N.V., Baxter International Inc., Epic Systems Corporation, Teladoc Health Inc., athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.

North America was the dominant region in the chronic disease management platforms market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in chronic disease management platforms report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic disease management platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic disease management platforms market includes revenues earned by entities by providing services such as software-as-a-service (SaaS) platform subscriptions, remote patient monitoring, care coordination and workflow automation, electronic health record (EHR) integration, predictive analytics and clinical decision support, telehealth and virtual care enablement, patient engagement tools, data analytics and reporting, implementation and system integration, customization of digital care pathways, training and support services, and ongoing maintenance and upgrades. The market value includes the value of related goods and embedded digital tools sold by the service provider or included within the platform offering. Only goods and services traded between entities or provided directly to end users are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The chronic disease management platforms market research report is one of a series of new reports from The Business Research Company that provides chronic disease management platforms market statistics, including chronic disease management platforms industry global market size, regional shares, competitors with a chronic disease management platforms market share, detailed chronic disease management platforms market segments, market trends and opportunities, and any further data you may need to thrive in the chronic disease management platforms industry. This chronic disease management platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Chronic Disease Management Platforms Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses chronic disease management platforms market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic disease management platforms ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chronic disease management platforms market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Solutions; Services
  • 2) By Disease Type: Cardiovascular Diseases; Diabetes; Cancer; Respiratory Diseases; Other Disease Types
  • 3) By End User: Healthcare Providers; Healthcare Payers
  • Subsegments:
  • 1) By Solutions: Population Health Management Solutions; Care Management Solutions; Patient Engagement Solutions; Telehealth Solutions; Remote Patient Monitoring Solutions; Clinical Decision Support Solutions; Healthcare Analytics Solutions
  • 2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Support And Maintenance Services; Managed Services
  • Companies Mentioned: Oracle Corporation; Koninklijke Philips N.V.; Baxter International Inc.; Epic Systems Corporation; Teladoc Health Inc.; athenahealth Inc.; Innovaccer Inc.; Amwell; CareCloud Inc.; Greenway Health LLC; Arcadia Solutions LLC; DarioHealth Corp.; Omada Health Inc.; TimeDoc Health LLC; ChartSpan Medical Technologies Inc.; Vida Health Inc.; HealthSnap Inc.; Optimize Health Inc.; CareHarmony LLC; Murphi AI Inc.; Mahalo Health Inc.; KangarooHealth Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Chronic Disease Management Platforms Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Chronic Disease Management Platforms Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Chronic Disease Management Platforms Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Chronic Disease Management Platforms Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Biotechnology, Genomics & Precision Medicine
    • 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
  • 4.2. Major Trends
    • 4.2.1 AI Powered Predictive Chronic Disease Risk Analytics Platforms
    • 4.2.2 IoT Enabled Remote Patient Monitoring Ecosystems
    • 4.2.3 Cloud Based Interoperable Electronic Health Record Integration Systems
    • 4.2.4 Precision Medicine Driven Personalized Chronic Care Pathways
    • 4.2.5 Blockchain Enabled Secure Patient Data Exchange Platforms

5. Chronic Disease Management Platforms Market Analysis Of End Use Industries

  • 5.1 Healthcare Providers
  • 5.2 Healthcare Payers
  • 5.3 Healthcare Technology Companies
  • 5.4 Pharmaceutical Companies
  • 5.5 Other End Users

6. Chronic Disease Management Platforms Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Chronic Disease Management Platforms Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Chronic Disease Management Platforms PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Chronic Disease Management Platforms Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Chronic Disease Management Platforms Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Chronic Disease Management Platforms Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Chronic Disease Management Platforms Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Chronic Disease Management Platforms Market Segmentation

  • 9.1. Global Chronic Disease Management Platforms Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solutions, Services
  • 9.2. Global Chronic Disease Management Platforms Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cardiovascular Diseases, Diabetes, Cancer, Respiratory Diseases, Other Disease Types
  • 9.3. Global Chronic Disease Management Platforms Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Healthcare Providers, Healthcare Payers
  • 9.4. Global Chronic Disease Management Platforms Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Population Health Management Solutions, Care Management Solutions, Patient Engagement Solutions, Telehealth Solutions, Remote Patient Monitoring Solutions, Clinical Decision Support Solutions, Healthcare Analytics Solutions
  • 9.5. Global Chronic Disease Management Platforms Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Implementation And Integration Services, Training And Education Services, Support And Maintenance Services, Managed Services

10. Chronic Disease Management Platforms Market, Industry Metrics By Country

  • 10.1. Global Chronic Disease Management Platforms Market, Average Selling Price By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $
  • 10.2. Global Chronic Disease Management Platforms Market, Average Spending Per Capita (Employed) By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $

11. Chronic Disease Management Platforms Market Regional And Country Analysis

  • 11.1. Global Chronic Disease Management Platforms Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 11.2. Global Chronic Disease Management Platforms Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. Asia-Pacific Chronic Disease Management Platforms Market

  • 12.1. Asia-Pacific Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. Asia-Pacific Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. China Chronic Disease Management Platforms Market

  • 13.1. China Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 13.2. China Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. India Chronic Disease Management Platforms Market

  • 14.1. India Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Japan Chronic Disease Management Platforms Market

  • 15.1. Japan Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 15.2. Japan Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Australia Chronic Disease Management Platforms Market

  • 16.1. Australia Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. Indonesia Chronic Disease Management Platforms Market

  • 17.1. Indonesia Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. South Korea Chronic Disease Management Platforms Market

  • 18.1. South Korea Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. South Korea Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. Taiwan Chronic Disease Management Platforms Market

  • 19.1. Taiwan Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. Taiwan Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. South East Asia Chronic Disease Management Platforms Market

  • 20.1. South East Asia Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. South East Asia Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. Western Europe Chronic Disease Management Platforms Market

  • 21.1. Western Europe Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 21.2. Western Europe Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. UK Chronic Disease Management Platforms Market

  • 22.1. UK Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. Germany Chronic Disease Management Platforms Market

  • 23.1. Germany Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. France Chronic Disease Management Platforms Market

  • 24.1. France Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Italy Chronic Disease Management Platforms Market

  • 25.1. Italy Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Spain Chronic Disease Management Platforms Market

  • 26.1. Spain Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Eastern Europe Chronic Disease Management Platforms Market

  • 27.1. Eastern Europe Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 27.2. Eastern Europe Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. Russia Chronic Disease Management Platforms Market

  • 28.1. Russia Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. North America Chronic Disease Management Platforms Market

  • 29.1. North America Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. North America Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. USA Chronic Disease Management Platforms Market

  • 30.1. USA Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. USA Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. Canada Chronic Disease Management Platforms Market

  • 31.1. Canada Chronic Disease Management Platforms Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. Canada Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. South America Chronic Disease Management Platforms Market

  • 32.1. South America Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 32.2. South America Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Brazil Chronic Disease Management Platforms Market

  • 33.1. Brazil Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Middle East Chronic Disease Management Platforms Market

  • 34.1. Middle East Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Middle East Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Africa Chronic Disease Management Platforms Market

  • 35.1. Africa Chronic Disease Management Platforms Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 35.2. Africa Chronic Disease Management Platforms Market, Segmentation By Type, Segmentation By Disease Type, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

36. Chronic Disease Management Platforms Market Regulatory and Investment Landscape

37. Chronic Disease Management Platforms Market Competitive Landscape And Company Profiles

  • 37.1. Chronic Disease Management Platforms Market Competitive Landscape And Market Share 2024
    • 37.1.1. Top 10 Companies (Ranked by revenue/share)
  • 37.2. Chronic Disease Management Platforms Market - Company Scoring Matrix
    • 37.2.1. Market Revenues
    • 37.2.2. Product Innovation Score
    • 37.2.3. Brand Recognition
  • 37.3. Chronic Disease Management Platforms Market Company Profiles
    • 36.3.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Epic Systems Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Teladoc Health Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Chronic Disease Management Platforms Market Other Major And Innovative Companies

  • athenahealth Inc., Innovaccer Inc., Amwell, CareCloud Inc., Greenway Health LLC, Arcadia Solutions LLC, DarioHealth Corp., Omada Health Inc., TimeDoc Health LLC, ChartSpan Medical Technologies Inc., Vida Health Inc., HealthSnap Inc., Optimize Health Inc., CareHarmony LLC, Murphi AI Inc., Mahalo Health Inc., KangarooHealth Inc.

38. Global Chronic Disease Management Platforms Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Chronic Disease Management Platforms Market

41. Chronic Disease Management Platforms Market High Potential Countries, Segments and Strategies

  • 41.1. Chronic Disease Management Platforms Market In 2030 - Countries Offering Most New Opportunities
  • 41.2. Chronic Disease Management Platforms Market In 2030 - Segments Offering Most New Opportunities
  • 41.3. Chronic Disease Management Platforms Market In 2030 - Growth Strategies
    • 41.3.1. Market Trend Based Strategies
    • 41.3.2. Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기